Phase II Study of Palifermin and Concurrent Chemoradiation in Head and Neck Squamous Cell CarcinomaBRIZEL, David M; MURPHY, Barbara A; ROSENTHAL, David I et al.Journal of clinical oncology. 2008, Vol 26, Num 15, pp 2489-2496, issn 0732-183X, 8 p.Article

Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-κB signaling as characteristics of a high-risk head and neck squamous cell carcinomaCHUNG, Christine H; PARKER, Joel S; LEVY, Shawn et al.Cancer research (Baltimore). 2006, Vol 66, Num 16, pp 8210-8218, issn 0008-5472, 9 p.Article

DEPRESSION IN PATIENTS WITH HEAD AND NECK CANCER AND A FUNCTIONAL GENETIC POLYMORPHISM OF THE SEROTONIN TRANSPORTER GENEGILBERT, Jill; HAMAN, Kirsten L; DIETRICH, Mary S et al.Head & neck. 2012, Vol 34, Num 3, pp 359-364, issn 1043-3074, 6 p.Article

HYPOTHYROIDISM AS A CONSEQUENCE OF INTENSITY-MODULATED RADIOTHERAPY WITH CONCURRENT TAXANE-BASED CHEMOTHERAPY FOR LOCALLY ADVANCED HEAD-AND-NECK CANCERDIAZ, Roberto; JABOIN, Jerry J; MURPHY, Patrick B et al.International journal of radiation oncology, biology, physics. 2010, Vol 77, Num 2, pp 468-476, issn 0360-3016, 9 p.Article

Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapySILVER, Heidi J; DIETRICH, Mary S; MURPHY, Barbara A et al.Head & neck. 2007, Vol 29, Num 10, pp 893-900, issn 1043-3074, 8 p.Article

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancerPOSNER, Marshall R; HERSHOCK, Diane M; MURPHY, Barbara A et al.The New England journal of medicine. 2007, Vol 357, Num 17, pp 1705-1715, issn 0028-4793, 11 p.Article

Phase ii trial of Docetaxel and cisplatin combination chemotherapy in Patients with squamous cell carcinoma of the head and neckGLISSON, Bonnie S; MURPHY, Barbara A; FRENETTE, Gary et al.Journal of clinical oncology. 2002, Vol 20, Num 6, pp 1593-1599, issn 0732-183XArticle

Head and Neck Carcinoma in the United States: First Comprehensive Report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN)KIAN ANG, K; CHEN, Amy; ADKINS, Douglas et al.Cancer. 2012, Vol 118, Num 23, pp 5783-5792, issn 0008-543X, 10 p.Article

Circadian regulation of locomotor activity and skeletal muscle gene expression in the horseMARTIN, Ann-Marie; ELLIOTT, Jeffrey A; MURPHY, Barbara A et al.Journal of applied physiology (1985). 2010, Vol 109, Num 5, pp 1328-1336, issn 8750-7587, 9 p.Article

Mucositis-Related Morbidity and Resource Utilization in Head and Neck Cancer Patients Receiving Radiation Therapy With or Without ChemotherapyMURPHY, Barbara A; BEAUMONT, Jennifer L; BELLM, Lisa A et al.Journal of pain and symptom management. 2009, Vol 38, Num 4, pp 522-532, issn 0885-3924, 11 p.Article

Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and NeckNEMUNAITIS, John; CLAYMAN, Gary; MENANDER, Kerstin A et al.Clinical cancer research (Print). 2009, Vol 15, Num 24, pp 7719-7725, issn 1078-0432, 7 p.Article

Quality of life research in head and neck cancer : A review of the current state of the scienceMURPHY, Barbara A; RIDNER, Sheila; WELLS, Nancy et al.Critical reviews in oncology/hematology. 2007, Vol 62, Num 3, pp 251-267, issn 1040-8428, 17 p.Article

Lack of efficacy of topotecan in the treatment of metastatic or recurrent squamous carcinoma of the head and neck : An Eastern Cooperative Oncology Group Trial (E3393)MURPHY, Barbara A; LEONG, Traci; BURKEY, Brian et al.American journal of clinical oncology. 2001, Vol 24, Num 1, pp 64-66, issn 0277-3732Article

Associations of oral health items of the Vanderbilt Head and Neck Symptom Survey with a dental health assessmentKOLNICK, Leanne; JIE DENG; EPSTEIN, Joel B et al.Oral oncology (1997). 2014, Vol 50, Num 2, pp 135-140, issn 1368-8375, 6 p.Article

Humoral response and antiviral cytokine expression following vaccination of thoroughbred weanlings—A blinded comparison of commercially available vaccinesGILDEA, Sarah; QUINLIVAN, Michelle; MURPHY, Barbara A et al.Vaccine. 2013, Vol 31, Num 45, issn 0264-410X, S216-S222Article

Phase II Efficacy and Pharmacogenomic Study of Selumetinib (AZD6244; ARRY-142886) in lodine-131 Refractory Papillary Thyroid Carcinoma with or without Follicular ElementsHAYES, D. Neil; LUCAS, Amy S; HOSKINS, Janelle et al.Clinical cancer research (Print). 2012, Vol 18, Num 7, pp 2056-2065, issn 1078-0432, 10 p.Article

Prevalence of Secondary Lymphedema in Patients With Head and Neck CancerJIE DENG; RIDNER, Sheila H; DIETRICH, Mary S et al.Journal of pain and symptom management. 2012, Vol 43, Num 2, pp 244-252, issn 0885-3924, 9 p.Article

Phase II Trial of Irinotecan Plus Cisplatin in Patients With Recurrent or Metastatic Squamous Carcinoma of the Head and NeckGILBERT, Jill; CMELAK, Anthony; SHYR, Yu et al.Cancer. 2008, Vol 113, Num 1, pp 186-192, issn 0008-543X, 7 p.Article

Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapyARGIRIS, Athanassios; YI LI; MURPHY, Barbara A et al.Journal of clinical oncology. 2004, Vol 22, Num 2, pp 262-268, issn 0732-183X, 7 p.Article

Improved communications and hearing protection in helmet systems: The communications earplugPOWELL, John A; KIMBALL, Kent A; MOZO, Ben T et al.Military medicine. 2003, Vol 168, Num 6, pp 431-436, issn 0026-4075, 6 p.Article

Recommended Patient-Reported Core Set of Symptoms to Measure in Head and Neck Cancer Treatment TrialsCHERA, Bhishamjit S; EISBRUCH, Avraham; MURPHY, Barbara A et al.Journal of the National Cancer Institute. 2014, Vol 106, Num 7, issn 0027-8874, dju127.1-dju127.4Article

Phase 1b, Multicenter, Single Blinded, Placebo-Controlled, Sequential Dose Escalation Study to Assess the Safety and Tolerability of Topically Applied AG013 in Subjects With Locally Advanced Head and Neck Cancer Receiving Induction ChemotherapySEWANTI ATUL LIMAYE; HADDAD, Robert I; CILLI, Fiona et al.Cancer. 2013, Vol 119, Num 24, pp 4268-4276, issn 0008-543X, 9 p.Article

VANDERBILT HEAD AND NECK SYMPTOM SURVEY VERSION 2.0: REPORT OF THE DEVELOPMENT AND INITIAL TESTING OF A SUBSCALE FOR ASSESSMENT OF ORAL HEALTHCOOPERSTEIN, Emily; GILBERT, Jill; EPSTEIN, Joel B et al.Head & neck. 2012, Vol 34, Num 6, pp 797-804, issn 1043-3074, 8 p.Article

Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): Analysis of Chemoradiation Treatment Approaches in the United StatesWONG, Stuart J; HARARI, Paul M; GARDEN, Adam S et al.Cancer. 2011, Vol 117, Num 8, pp 1679-1686, issn 0008-543X, 8 p.Article

Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-GalactoseCHUNG, Christine H; MIRAKHUR, Beloo; SLEBOS, Robbert J et al.The New England journal of medicine. 2008, Vol 358, Num 11, pp 1109-1117, issn 0028-4793, 9 p.Article